NYSE:DHR

Danaher (DHR) Stock Forecast, Price & News

$251.70

-0.30 (-0.12%)

(As of 05/25/2022 03:24 PM ET)

Add

Compare

Today's Range: $246.82
▼
$251.94
50-Day Range: $237.11
▼
$299.66
52-Week Range: $233.71
▼
$333.96

Volume: 141,600 shs
Average Volume: 2.96 million shs
Market Capitalization: $183.01 billion

P/E Ratio: 29.13
Dividend Yield: 0.40%
Beta: 0.84

30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

May 24, 2022 | seekingalpha.com

Danaher: A Holding To Cover An Entire Sector (NYSE:DHR) - Seeking Alpha

May 24, 2022 | nasdaq.com

Danaher Stock: Attractively Priced Following the Recent Correction - Nasdaq

May 17, 2022 | finance.yahoo.com

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

May 16, 2022 | seekingalpha.com

Danaher Corporation (DHR) CEO Rainer Blair Presents at Bank of America Securities Health Care Conference (Transcript) - Seeking Alpha

May 15, 2022 | apnews.com

Rockefeller home on Maine's Mount Desert Island to be razed - The Associated Press - en Español

May 14, 2022 | finance.yahoo.com

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases - Yahoo Finance

May 13, 2022 | finance.yahoo.com

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

May 11, 2022 | seekingalpha.com

Danaher declares $0.25 dividend

May 11, 2022 | nasdaq.com

Oversold Conditions For Danaher (DHR)

May 10, 2022 | seekingalpha.com

Danaher declares $0.25 dividend (NYSE:DHR) - Seeking Alpha

May 9, 2022 | benzinga.com

Global Coding and Marking Equipment Market (2021 to 2027) - Featuring Hitachi, Danaher, Matthews Internat - Benzinga

May 9, 2022 | nasdaq.com

Comparing Cardano Versus Danaher Reveals New High - Nasdaq

May 9, 2022 | businesswire.com

Outlook on the Microcarrier Global Market to 2027 - Key Players Include Thermo Fisher Scientific, Merck, Eppendorf and Danaher Among Others - ResearchAndMarkets.com - Business Wire

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Process control instruments
Sub-Industry: Industrial Conglomerates
Sector: Multi-Sector Conglomerates
Current Symbol: NYSE:DHR
Previous Symbol
CUSIP: 23585110
CIK: 313616
Web: www.danaher.com
Phone: (202) 828-0850
Fax: 202-828-0860
Employees: 80,000
Year Founded: 1984

Sales & Book Value

Annual Sales: $29.45 billion
Price / Sales: 6.21
Cash Flow: $13.72 per share
Price / Cash Flow: 18.34
Book Value: $59.27 per share
Price / Book: 4.25

Profitability

EPS (Most Recent Fiscal Year): $8.639990
Net Income: $6.43 billion
Net Margins: 21.32%
Pretax Margin: 25.14%
Return on Equity: 18.64%
Return on Assets: 9.38%

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.68
Quick Ratio: 1.27

Price-To-Earnings

Trailing P/E Ratio: 29.13
Forward P/E Ratio: 24.41
P/E Growth: 2.77

Miscellaneous

Outstanding Shares: 727,077,000
Free Float: 645,644,000
Market Cap: $183.01 billion
Optionable: Optionable

Company Calendar

Ex-Dividend for 4/29 Dividend: 3/24/2022
Last Earnings: 4/21/2022
Dividend Payable: 4/29/2022
Today: 5/25/2022
Next Earnings (Estimated): 7/28/2022
Fiscal Year End: 12/31/2022

Social Links

MarketRank^™

Overall MarketRank^™

2.98 out of 5 stars

Multi-Sector Conglomerates Sector

6th out of 28 stocks

Process Control Instruments Industry

2nd out of 17 stocks

3.4 Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Buy. The company's average rating score is 2.85, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $335.23, Danaher has a forecasted upside of 34.6% from its current price of $248.97.
Amount of Analyst Coverage
Danaher has only been the subject of 4 research reports in the past 90 days.

5.0 Community Rank

Outperform Votes
Danaher has received 970 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Danaher has received 295 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Danaher has received 76.68% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote “Outperform” if you believe DHR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
Danaher has a dividend yield of 0.40%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Danaher has been increasing its dividend for 6 years.
Dividend Coverage
The dividend payout ratio of Danaher is 11.57%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 9.26% next year. This indicates that Danaher will be able to sustain or increase its dividend.

3.3 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,662,310.00 in company stock.
Percentage Held by Insiders
11.20% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
78.42% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 4.75% in the coming year, from $10.31 to $10.80 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 28.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 9.87.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 28.82, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 7.00.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 2.77. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 4.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher or view top-rated stocks.
When is Danaher's next earnings date?: Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022.
View our earnings forecast for Danaher.
How were Danaher's earnings last quarter?: Danaher Co. (NYSE:DHR) announced its quarterly earnings results on Thursday, April, 21st. The conglomerate reported $2.76 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.11. The conglomerate earned $7.69 billion during the quarter, compared to analysts' expectations of $7.53 billion. Danaher had a trailing twelve-month return on equity of 18.64% and a net margin of 21.32%. The company's quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.52 earnings per share.
View Danaher's earnings history.
How often does Danaher pay dividends? What is the dividend yield for Danaher?: Danaher announced a quarterly dividend on Tuesday, May 10th. Stockholders of record on Friday, June 24th will be paid a dividend of $0.25 per share on Friday, July 29th. This represents a $1.00 annualized dividend and a dividend yield of 0.40%. The ex-dividend date is Thursday, June 23rd.
View Danaher's dividend history.
Is Danaher a good dividend stock?: Danaher pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.40%. Danaher has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Danaher is 11.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 9.26% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.
What price target have analysts set for DHR?: 13 Wall Street analysts have issued twelve-month target prices for Danaher's shares. Their forecasts range from $265.00 to $370.00. On average, they anticipate Danaher's stock price to reach $335.23 in the next year. This suggests a possible upside of 33.2% from the stock's current price.
View analysts' price targets for Danaher or view top-rated stocks among Wall Street analysts.
Who are Danaher's key executives?: Danaher's management team includes the following people:
Mr. Steven M. Rales, Co-Founder & Chairman (Age 71)
Mr. Rainer M. Blair, Pres, CEO & Director (Age 58, Pay $5.77M) (LinkedIn Profile)
Mr. Mitchell P. Rales, Co-Founder & Director (Age 65)
Mr. Matthew R. McGrew, CFO & Exec. VP (Age 50, Pay $2.68M) (LinkedIn Profile)
Ms. Angela S. Lalor, Part Time Advisor (Age 57, Pay $3.23M) (LinkedIn Profile)
Mr. Joakim Weidemanis, Exec. VP (Age 53, Pay $3.06M) (LinkedIn Profile)
Ms. Jennifer L. Honeycutt, Exec. VP (Age 52, Pay $2.44M)
Mr. Christopher M. Bouda, Chief Accounting Officer
Dr. Jose-Carlos Gutierrez-Ramos Ph.D., Sr. VP & Chief Science Officer (Age 57)
Mr. John Bedford, VP of Investor Relations
What is Rainer M. Blair's approval rating as Danaher's CEO?: 27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
Who are some of Danaher's key competitors?: Some companies that are related to Danaher include Roper Technologies (ROP), AMETEK (AME), Keysight Technologies (KEYS), Fortive (FTV), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Senseonics (SENS), Senseonics (SENS), Hurco Companies (HURC), Crawford United (CRAWA), Sypris Solutions (SYPR), International Isotopes (INIS) and ClearSign Technologies (CLIR).
View all of DHR's competitors.
What other stocks do shareholders of Danaher own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).
What is Danaher's stock symbol?: Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
Who are Danaher's major shareholders?: Danaher's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.02%), Edgewood Management LLC (1.12%), Northern Trust Corp (1.10%), Bank of New York Mellon Corp (0.95%), Parnassus Investments LLC (0.62%) and Fisher Asset Management LLC (0.52%). Company insiders that own Danaher stock include Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Elias A Zerhouni, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr and William King.
View institutional ownership trends for Danaher.
Which institutional investors are selling Danaher stock?: DHR stock was sold by a variety of institutional investors in the last quarter, including Canada Pension Plan Investment Board, Third Point LLC, Harding Loevner LP, Cibc World Markets Corp, Bellevue Group AG, Toronto Dominion Bank, Group One Trading L.P., and Northern Trust Corp. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel Raskas, Elias A Zerhouni, Joakim Weidemanis, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Robert S Lutz, and Teri List.
View insider buying and selling activity for Danaher or view top insider-selling stocks.
Which institutional investors are buying Danaher stock?: DHR stock was bought by a variety of institutional investors in the last quarter, including AustralianSuper Pty Ltd, Vanguard Group Inc., Flossbach Von Storch AG, Sustainable Growth Advisers LP, Eaton Vance Management, Renaissance Technologies LLC, Swiss National Bank, and KBC Group NV.
View insider buying and selling activity for Danaher or or view top insider-buying stocks.
How do I buy shares of Danaher?: Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Danaher's stock price today?: One share of DHR stock can currently be purchased for approximately $251.70.
How much money does Danaher make?: Danaher has a market capitalization of $183.01 billion and generates $29.45 billion in revenue each year. The conglomerate earns $6.43 billion in net income (profit) each year or $8.639990 on an earnings per share basis.
How many employees does Danaher have?: Danaher employs 80,000 workers across the globe.
Does Danaher have any subsidiaries?: The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aldevron, Aldevron L.L.C., American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology Suzhou Co. Ltd., Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise China Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd, Beckman Coulter Laboratory Systems Suzhou Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Finance ApS, Biacore International AB, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Canada ULC, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid India Private Limited, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology Guangzhou Co. Ltd., Cytiva Biotechnology Hang Zhou Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, DCHL Holding BV, DH Denmark Holding ApS, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Holdings Germany LLC, DH II Luxembourg Sarl, DH Japan Finance Sarl, DH Switzerland Finance Sarl, DH Technologies Development Pte Ltd., DHCY Limited, DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher China Holdings Ltd., Danaher Finance Company AB, Danaher HK Holdings Ltd., Danaher Medical ApS, Danaher Shanghai Management Co. Ltd., Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Graphics BV, Esko Graphics Inc., Esko Software BV, Fluke, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies Japan KK, Global Life Sciences Technologies Shanghai Co Ltd., Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. Shanghai Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, ID Business Solutions Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Intermountain Life Sciences LLC, Iris International Inc., KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Launchchange Holding Company, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments Singapore Pte Limited, Leica Microsystems, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems UK Limited, Leica Mikrosysteme GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Life Sciences IP Holdings Corporation, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nobel Biocare, OTT Hydromet Corp, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Austar Lifesciences Limited, Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Canada ULC, Pall China Co. Ltd., Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Schweiz GmbH, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, Precision Nanosystems ULC, Radiometer, Radiometer Medical ApS, Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Sedaru Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Skyland Analytics Inc., Sutron, Swift Biosciences Inc., Sybron Dental Specialties, Tektronix, Thomson Industries, Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Vanrx Pharmasystems Inc., Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies Europe B.V., Videojet Technologies GmbH, Videojet Technologies Inc., Videojet Technologies S Pte.Ltd., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..
When was Danaher founded?: Danaher was founded in 1984.
What is Danaher's official website?: The official website for Danaher is www.danaher.com.
How can I contact Danaher?: Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at (202) 828-0850, via email at [email protected], or via fax at 202-828-0860.

This page was last updated on 5/25/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Danaher (DHR) Stock Forecast, Price & News

About Danaher

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

Social Links

MarketRank™

Overall MarketRank™

3.4 Analyst's Opinion

5.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

2.5 Dividend Strength

3.3 Company Ownership

0.6 Earnings and Valuation

Danaher (NYSE:DHR) Frequently Asked Questions

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™